Methylprednisolone acetate vs Certolizumab pegol
National NHS prescribing compared (Prescription Cost Analysis)
Methylprednisolone acetate was dispensed 72,033.0× as often as Certolizumab pegol in June 2026 — 72,033 items versus 1 in England.
72,033items
Methylprednisolone acetate · June 2026
NHSBSA Prescription Cost Analysis
1items
Certolizumab pegol · June 2026
NHSBSA Prescription Cost Analysis
Figure 1. Methylprednisolone acetate versus Certolizumab pegol: national items dispensed by month
▬ Methylprednisolone acetate · ╌ Certolizumab pegol
Source: NHSBSA Prescription Cost Analysis, to June 2026
| Measure | Methylprednisolone acetate | Certolizumab pegol |
|---|---|---|
| Items, June 2026 | 72,033 | 1 |
| Items, last 12 months | 765,230 | 6 |
| Net ingredient cost, June 2026 | £350,309 | £358 |
See the full profile for Methylprednisolone acetate or Certolizumab pegol.